At least 36 people have developed a rare Life-threatening blood disorder called thrombocytopenia, and one of them died after receiving one of two COVID-19 (Chinese Communist Virus) vaccines licensed in the United States.
Dr. Gregory Michael, a Miami obstetrician, died of thrombocytopenia, in which his platelets dropped to almost zero after he received the vaccine. Michael, who was only 56 years old, died of a brain hemorrhage just 16 days after receiving the Pfizer vaccine.
According to details disclosed by his wife, Heidi Neckelmann, Michael noticed small spots on his skin three days after he received his first dose of the vaccine. He realized that the spots indicated possible internal bleeding, and hospital tests showed that his blood cell count was well below normal, and after more than 10 days of treatment, his platelet count never rose.
According to a report submitted to the Vaccine Adverse Event Reporting System (VAERS), 36 similar cases had been reported to the U.S. public by the end of January.
According to the New York Times, the cases involved a vaccine developed by Pfizer in collaboration with German drugmaker BioNTech, or Moderna, the only two vaccines approved for emergency use in the United States to date. Thrombocytopenia is basically a deficiency of platelets, a blood component essential for blood clotting.
According to the Daily Mail, thrombocytopenia has occurred after other vaccines have been administered, and experts suspect that the vaccination does act as a trigger in some way – they just don’t know why. But so far, the platelet-suppressing condition appears to be extremely rare, affecting only 36 people out of 43 million vaccine doses administered in the U.S. Scientists have concluded that only a small percentage of people have some sort of trigger in their bodies that could cause the vaccine to trigger the blood disorder.
In a statement, Pfizer said Michael’s case passed away because of internal bleeding due to insufficient blood clotting in the body, a fairly serious and rare occurrence, although Pfizer believes it should not be directly related to the vaccination. “We take the reporting of adverse events very seriously,” Pfizer said, adding that the company also closely monitors vaccine recipients for subsequent adverse reactions.
The New York Times noted that Moderna also provided a statement that did not address the issue of platelet disorders, but said the company “continuously monitors the safety of the Moderna COVID-19 vaccine using all data sources” and regularly shares safety information with regulators.
Recent Comments